BFA
FCSC

BlackRock Fund Advisors’s Fibrocell Science Inc. FCSC Stock Holding History

BlackRock Fund Advisors’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$40K Buy
4,195
+145
+4% +$1.56K ﹤0.01% 3804
2016
Q3 		$44K Buy
4,050
+3
+0.1% +$44 ﹤0.01% 3810
2016
Q2 		$70K Sell
4,047
-39,796
-91% -$1.24M ﹤0.01% 3755
2016
Q1 		$1.64M Sell
43,843
-2,513
-5% -$100K ﹤0.01% 3120
2015
Q4 		$3.16M Buy
46,356
+1,263
+3% +$90.7K ﹤0.01% 3028
2015
Q3 		$2.6M Buy
45,093
+1,854
+4% +$164K ﹤0.01% 3058
2015
Q2 		$3.42M Buy
43,239
+38,748
+863% +$2.61M ﹤0.01% 3064
2015
Q1 		$304K Sell
4,491
-304
-6% -$19.6K ﹤0.01% 3373
2014
Q4 		$186K Buy
4,795
+342
+8% +$13.8K ﹤0.01% 3505
2014
Q3 		$194K Sell
4,453
-323
-7% -$15.1K ﹤0.01% 3482
2014
Q2 		$286K Sell
4,776
-37,139
-89% -$2.07M ﹤0.01% 3360
2014
Q1 		$3.29M Buy
41,915
+1,834
+5% +$142K ﹤0.01% 3028
2013
Q4 		$2.44M Buy
40,081
+7,790
+24% +$453K ﹤0.01% 3112
2013
Q3 		$2.12M Buy
32,291
+3,725
+13% +$301K ﹤0.01% 3116
2013
Q2 		$2.62M Buy
+28,566
New +$2.36M ﹤0.01% 3043

Other funds holding FCSC

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock Fund Advisors's FCSC Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Fibrocell Science Inc. (FCSC) stake by 3.6% in Q4 2016, buying an estimated $1.56K and bringing the position to 4,195 shares worth $40K. The position accounts for ﹤0.01% of the portfolio, ranked #3804.

BlackRock Fund Advisors first reported a position in FCSC in Q2 2013 and has held it in 15 quarters since. The position peaked at $3.42M in Q2 2015. 30 funds tracked by Wall St. Rank hold FCSC as of Q4 2016.

  • BlackRock Fund Advisors held 4,195 shares of Fibrocell Science Inc. worth $40K as of Q4 2016.
  • BlackRock Fund Advisors bought 145 Fibrocell Science Inc. shares in Q4 2016, an estimated $1.56K.
  • Fibrocell Science Inc. made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3804 holding.
  • BlackRock Fund Advisors first reported a position in Fibrocell Science Inc. in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Fibrocell Science Inc. position peaked at $3.42M in Q2 2015.
  • 30 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.